Polyrizon

Polyrizon Diluted EPS

The Diluted Earnings per Share of Polyrizon (PLRZ) as of Nov 20, 2026 is -2.07 USD. In the previous year, Diluted Earnings per Share was -114.44 USD — a change of -98.19% (higher).

Diluted EPS

-2.07USD

YoY

-98.19%

Last updated:

Diluted Earnings per Share of Polyrizon is 2025 -2.07 USD. Diluted Earnings per Share of Polyrizon was 2024 -114.44 USD. It decreases by -98.19% higher compared to the previous year.

The Polyrizon Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2020
-0.02 USD
Jan 1, 2021
-0.17 USD
Jan 1, 2022
-0.19 USD
Jan 1, 2023
-0.14 USD
Jan 1, 2024
-114.44 USD
Jan 1, 2025
-2.07 USD
The Polyrizon Diluted EPS history
YEARDiluted EPSYoY
-2.07USD-98.19%
-114.44USD+79,904.30%
-0.14USD-22.98%
-0.19USD+9.56%
-0.17USD+873.97%
-0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

Diluted Earnings per Share of Polyrizon is -2.07 USD in 2025.

Diluted Earnings per Share of Polyrizon changed from -114.44 USD to -2.07 USD, representing a -98.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Polyrizon since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Polyrizon

All Key Metrics — Polyrizon